knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 23:00:01 - browse：51286

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Readout Newsletter: The latest at Gilead, Catalent, and the NIH

WSS

PBM reforms clear House panel

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Biotech investment managers search for lucrative opportunities

Pregnancy ages women, but effects reverse after delivery

Morphosys mixed study results for blood cancer drug

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

knowledge

knowledge

focus

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Hepatitis C has a cure — but many Americans still lack access to it

World's first CRISPR

Duchenne breakthrough therapy leaves behind pioneering families

CRISPR technology availability, affordability needs to be expanded

In age of alternative facts, a scholarly course on calling out crap

Surgeons perform first xenotransplant using CRISPR'd pig kidney

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Wikipedia

Cancer, immunology, HIV research ensnared in fetal tissue politics

Does good food count as health care? Study aims to find out

Biotech investment managers search for lucrative opportunities

Weight loss drug costs may need more research, senator suggests

Medicare Advantage insurers pressure Biden for bigger payments

Biotech investment managers search for lucrative opportunities

focus

focus

focus

hotspot